dc.date.accessioned | 2016-03-14T13:37:59Z | |
dc.date.available | 2016-03-14T13:37:59Z | |
dc.date.created | 2015-07-20T10:02:18Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Balasegaram, Manica Brechot, Christian Farrar, Jeremy Heymann, David Ganguly, Nirmal Khor, Martin Levy, Yves Matsoso, Precious Minghui, Ren Pecoul, Bernard Peilong, Liu Tanner, Marcel Røttingen, John-Arne . A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance. PLoS Medicine. 2015, 12(5) | |
dc.identifier.uri | http://hdl.handle.net/10852/49828 | |
dc.description.abstract | Anti-microbial resistance, emerging infectious diseases, and neglected diseases are all important public health concerns and priorities with serious market failures, deficits, and identified needs in biomedical innovation.
It is important to reconcile, rather than fragment, the needs of these three priority areas by considering an umbrella framework for specifically financing and coordinating research and development (R&D) that delivers innovation while securing patient access.
A sizeable, sustainably financed global R&D fund and mechanism that promotes coordination, collaboration, and utilization of new and innovative incentives should be set up to cover all three priority areas. | en_US |
dc.language | EN | |
dc.language.iso | en | en_US |
dc.publisher | Public Library of Science (PLoS) | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance | en_US |
dc.type | Journal article | en_US |
dc.creator.author | Balasegaram, Manica | |
dc.creator.author | Brechot, Christian | |
dc.creator.author | Farrar, Jeremy | |
dc.creator.author | Heymann, David | |
dc.creator.author | Ganguly, Nirmal | |
dc.creator.author | Khor, Martin | |
dc.creator.author | Levy, Yves | |
dc.creator.author | Matsoso, Precious | |
dc.creator.author | Minghui, Ren | |
dc.creator.author | Pecoul, Bernard | |
dc.creator.author | Peilong, Liu | |
dc.creator.author | Tanner, Marcel | |
dc.creator.author | Røttingen, John-Arne | |
cristin.unitcode | 185,52,0,0 | |
cristin.unitname | Institutt for helse og samfunn | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |
dc.identifier.cristin | 1254416 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLoS Medicine&rft.volume=12&rft.spage=&rft.date=2015 | |
dc.identifier.jtitle | PLoS Medicine | |
dc.identifier.volume | 12 | |
dc.identifier.issue | 5 | |
dc.identifier.pagecount | 4 | |
dc.identifier.doi | http://dx.doi.org/10.1371/journal.pmed.1001831 | |
dc.identifier.urn | URN:NBN:no-53547 | |
dc.type.document | Tidsskriftartikkel | en_US |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 1549-1277 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/49828/1/Balasegaram_2015_Agl.pdf | |
dc.type.version | PublishedVersion | |
cristin.articleid | e1001831 | |